JPRN-UMIN000038867招募中未知
Sequential therapy for hepatocellular carcinoma -Real world evidence of TKI in prospective observational study- - HAMRET study
Kyushu Study group of Clinical Cancer0 个研究点目标入组 500 人开始时间: 2020年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •#1.Patients with a past history of treatment for systemic therapy #2.Patients participating in another interventional clinical trials
研究者
相似试验
已完成
不适用
Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External RadiationHepatocellular CarcinomaNCT04813861Central Hospital, Nancy, France57
进行中（未招募）
不适用
Treatment of advanced hepatocellular carcinoma (HCC) with portal vein thrombosis by hepatic intra-arterial injection of microspheres loaded with Yttrium-90 (Thera-Sphere) - RAD-09advanced hepatocellular carcinoma (HCC) with portal vein thrombosisMedDRA version: 9.1Level: LLTClassification code 10024662MedDRA version: 9.1Level: PTClassification code 10019713EUCTR2009-016475-29-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
进行中（未招募）
1 期
Hepatocellular carcinoma less than 3 cm treated with percutaneous tumour destruction: multicentric phase 2 trial assessing the impact of idarubicin-lipiodol intra-arterial chemotherapy on hepatic recurrence.The research hypothesis is that hepatic locoregional treatment with idarubicin and lipiodol would be an effective adjuvant therapy of hepatocellular carcinomaEUCTR2019-001362-15-FRniversity Hospital of Montpellier138
招募中
不适用
HEpatocellular carcinoma stereotactic RAdiotherapy CLinical Evaluation StudyC22.0Liver cell carcinomaDRKS00008566niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde75
已完成
不适用
Prognosis of patient with hepatocellular carcinoma in chronic hepaitits C.Hepatitis CJPRN-C000000227Ikeda Municipal Hospital100